我们的网站为什么显示成这样？

可能因为您的浏览器不支持样式，您可以更新您的浏览器到最新版本，以获取对此功能的支持，访问下面的网站，获取关于浏览器的信息：

|本期目录/Table of Contents|

药物涂层支架的研究进展(PDF)

《心脏杂志》[ISSN:1009-7236/CN:61-1268/R]

期数:
2004年第5期
页码:
476-479
栏目:
综述
出版日期:
2004-09-01

文章信息/Info

Title:
-
作者:
李慧丽1; 王彬尧1; 黄定九1; 万锕俊2
1. 上海第二医科大学附属仁济医院心内科,上海200001 ; 2. 上海交通大学化学系,上海200240
Author(s):
-
关键词:
涂层支架; 药物; 再狭窄
Keywords:
-
分类号:
R543. 3
DOI:
-
文献标识码:
A
摘要:
药物涂附支架解决了抑制血管成形术后再狭窄靶部位有效药物浓度和药物作用时间问题,具有代表性的药 物涂附支架包括雷帕霉素支架、Taxol 支架和肝素涂层支架,以及一氧化氮及其衍生物涂层支架和水蛭素涂层支架 等。雷帕霉素支架和Taxol 支架的动物和临床研究获得了较好实验结果。药物涂层支架防治再狭窄的长期效果尚 需通过严格设计的动物实验和随机、双盲、安慰剂对照的大规模临床研究才能作出客观评价。
Abstract:
-

参考文献/References

[1 ] Gummert JF , Ikonen T , Morris RE. Newer immunosuppressive drugs : a review[J ] . J Am Soc Nephrol , 1999 ,10 :1366 - 1380.

[ 2 ] Gregory CR , Huie P , BillinghamME , et al . Rapamycin inhibits arterial intimal thickening caused by both alloimmuoe and mechanical injury. Its effect on cellular , growth factor , and cytokine response in injured vessels [J ] . Transplantation , 1993 , 55 :1409 - 1418.

[3 ] Poon M. Marx So , Gallo R , et al . Rapamycin inhibit vascular smooth muscle cell migration[J ] . Clin Invest ,1996 ,98 (10) :2277 - 2283.

[4 ] Marx So. Jayaraman T , Go Lo , et al . Rapamycin - FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells[J ] . CircRes , 1995 ,76 :412 - 417.

[5 ] Gallo R , Padurean A , Jayaraman T , et al . Inhibition of intimal thickening after balloon angioplasty in porcine coronary arteries by targeting ragulators of the cell cycle[J ] . Circulation , 1999 , 99 (16) :2164 - 2170.

[6 ] Suzuki K, Kopia G, Bailey L , et al . Stent-based delivery of sirolimus reduces neointimal formation and in-stent restenosis in a porcine coronary model [J ] . Circulation , 2001 ,104 (10) :1188 - 1193.

[7 ] Sousa JE , Costa MA , Abizaid A , et al . Lack of neoinfimal proliferation after implantation of sirolimus2coated stents in human coronary arteries : a quantitative coronary angiography and three-imensional intrarascular ultrasound study[J ] . Circulation , 2001 ,103 (1) :192 - 195.

[8 ] Sousa JE , Costa MA , Abizaid A , et al . Mid-(4 months) and long-term (1 year) QCA and three-dimensional IVUSfollow-up after inplantation of sirolimus- coated stents in human coronary arteries [ abstract ] [J ] . J Am Coll Cardiol , 2001 ,37 :8A.

[9 ] Rensing B , Vos J , Smits P , et al . Coronary restenosis elimination with a sirolimus eluting stent . First European human experience with six month angiographic and intrarascular ultrasonic follow-up[J ] . Eur Heart J , 2001 ,22 :2125 - 2130.

[ 10 ]Morice M, Serruys P , sousa J , et al . The RAVEL study : a randomized study with the sirolimus coated Bx velocity balloon2expandable stent in the treatment of patients with de novo native coronary artery lesious[ abstract ] [J ] . Eur Heart J , 2001 ,22 (suppl) :484.

[ 11 ]Serruys PW, Regar E , Carter AJ . Rapamycin eluting stent : the onset of new era in international cardiology [J ] . Heart , 2002 , 87 (4) : 305 -307.

[ 12 ]Schiff PB , Horwitz SB. Taxol stabilizes microtubules in mouse fibroblast cells[J ] . PNAS , 1980 , 77 :1561 - 1565.

[13 ]Sollott SJ . Cheng L , Pauly RR , et al . Taxol inhibits neointimal smooth muscle cell accumulation after angioplasty in the rat [J ] . J Clin Invest ,1995 ,95 (4) :1869 - 1876.

[14 ]Axel DI , Kunert W, Gogglmann C , et al . Paclitaxel inhibits artetial smooth muscle proliferation and migration in vitro and in vivo using local drug delivery[J ] . Circulation , 1997 ,96 (3) :635 - 645.

[15 ]Drachman DE , Edelman ER , Seifert P , et al . Neointimal thickening after stent delivery of paclitaxel : change in composition and arrest of growth over six months[J ] . J Am Coll Cardiol , 2000 ,36 (7) :2325 -2332.

[16 ]Heldman AW, ChengL , Jenkins GM, et al . Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis[J ] . Circulation , 2001 ,103 (18) :2289 - 2295.

[ 17 ]Farb A , Heller PF , Shroff S , et al . Pathological analysis of local delivery of paclitaxel via a polymer2coated stent [J ] . Circulation , 2001 ,104(4) :473 - 479.

[18 ]Liistro F , Stankovic G, Di Mario C , et al . First clinical experience with a paclitaxel derivate- eluting polymer stent system implantation for in2stent restenosis : immediate and long2term clinical and angiographic outcome[J ] . Circulation ,2002 ,105 (16) :1883 - 1886.

[19 ]Ahn YK, Jeong MH , KimJW, et al . Preventive effects of the heparin-coated stent on restenosis in the porcine model [J ] . Catheter cardiovasc Interv , 1999 ,48(3) :324 - 330.

[20 ]Atsumoto Y, Shimokawa H , Morishige K, et al . Reduction in neointimal formation with a stent coated with multiple layers of releasable heparin in porcine coronary arteries[J ] . J Cardiovasc Pharmacol , 2002 ,39 (4) :513 - 522.

[21 ]Wohrle J , Al2hayer E , Grotzinger V , et al . Comparison of the heparin coated vs the uncoated stent-no influence on restenosis or clinical outcome[J ] . Eur Heart J ,2001 ,22(19) :1766 - 1768.

[22 ]Buergler JM, tio FO , Schulz DG, et al . Use of nitric-oxide-eluting polymer - coated coronary stents for prevention of restenosis in pigs[J ] .Coron Artery Dis , 2000 ,11 (4) :351 - 357.

[23 ]Yoon JH , Wu CJ , Homme J , et al . Local delivery of nitric oxide from an eluting stent to inhibit neointimal thickening in a porcine coronary injury model [J ] . Yonsel Med J , 2002 ,43 (2) :242 - 251.

[24 ]Alt E , Haehnel I , Beilharz C , et al . Inhibition of neointima formation after experimental coranary artery stenting : a new biodegradable stent coating releasing hirudin and prostacyclin analogue iloprost [J ] . Circulation , 2000 ,101 (12) :1453 - 1458.

备注/Memo

备注/Memo:
收稿日期：2003-10-28
更新日期/Last Update: 2004-09-01